An adjuvanted subunit SARS-CoV-2 spike protein vaccine provides protection against Covid-19 infection and transmission

Abstract Recombinant protein approaches offer major promise for safe and effective vaccine prevention of SARS-CoV-2 infection. We developed a recombinant spike protein vaccine (called NARUVAX-C19) and characterized its ability when formulated with a nanoemulsion adjuvant to induce anti-spike antibod...

Descripció completa

Dades bibliogràfiques

Autors principals:	Kairat Tabynov, Nurkeldi Turebekov, Meruert Babayeva, Gleb Fomin, Toktassyn Yerubayev, Tlektes Yespolov, Lei Li, Gourapura J. Renukaradhya, Nikolai Petrovsky, Kaissar Tabynov
Format:	Artigo
Idioma:	Inglês
Publicat:	Nature Portfolio 2022-02-01
Col·lecció:	npj Vaccines
Accés en línia:	https://doi.org/10.1038/s41541-022-00450-8
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!